Veradermics Showcases Positive Phase 2/3 Data: VDPHL01 Could Become the First FDA-Approved Oral Non-Hormonal Treatment for Pattern Hair Loss
Market Chameleon (Fri, 17-Jul 11:50 AM)
MANE: Oral VDPHL01 Shows Promising Phase 2 Results in Female Pattern Hair Loss—Phase 2/3 Readout Expected in 2027
Market Chameleon (Wed, 15-Jul 8:33 AM)
